Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Suzhou Ark Biopharmaceutical patents respiratory syncytial virus inhibitors

Aug. 24, 2021

New NLRP3 inflammasome inhibitors patented by Roche, Genentech

Aug. 24, 2021

Icahn School of Medicine at Mount Sinai presents new arylsulfonamide derivatives

Aug. 24, 2021

New SUMO-activating enzyme subunit 1 inhibitors identified at Oncovalent Therapeutics

Aug. 24, 2021

Shanghai Bowei Biological Technology, collaborators divulge polynucleotides for expressing HPV 51L1

Aug. 23, 2021

New SREBP inhibitors identified at Capulus Therapeutics

Aug. 23, 2021

Sumitomo Dainippon Pharma Oncology patents serine/threonine kinase Nek2 inhibitors

Aug. 23, 2021

Genexine describes anti-TAA, anti-PD-L1, TNFRSF9 ligand fusion proteins

Aug. 23, 2021

CRISPR Therapeutics AG presents new CAR Tcells for immuno-oncology

Aug. 20, 2021

Children's Medical Center patents ALK CAR for melanoma and neuroblastoma

Aug. 20, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.